A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The purpose of this study is to assess the effect of nipocalimab treatment on the antibody (a protein made in the body to response to a foreign substance) response following tetanus, diphtheria, pertussis (Tdap) vaccination in healthy participants at Week 4.
Epistemonikos ID: 0375479b59b1df083f408f3472b4975de5490e4e
First added on: Feb 19, 2024